Comparison of PRISM III, PIM2 and PELOD Scoring Systems

NCT04848168 | Completed

• 1 other identifier: Dr. Siyami Ersek TRH
• Study Type: observational
• Target: 116
• Locations: 1 country
• Sites: 1

Brief Summary

PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pediatric ICUs(Intensive Care Units). However, the effectiveness of these scoring sistems in a specific group patients undergoing congenital heart surgery(CHS) is unknown. In this study, the investigators aimed primarily to evaluate the success of these scoring systems in predicting mortality and morbiditiy in this specific group and to compare the scoring systems with eachother, and secondly to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

Conditions

Congenital Heart Disease

Keywords

PRISM III; PIM2; PELOD; STAT; mortality; congenital heart disease

Outcome Measures

Primary Outcomes (3)

• evaluate the success of PRISMIII, PIM2 and PELOD scoring systems in predicting mortality and morbidity

  Patients younger than 18 years of age who had undergone congenital heart surgery were evaluated on the first postoperative day in the ICU and parameters were recorded. PRISMIII and PELOD scores were calculated using the most abnormal values in the first 24 hours, and PIM2 score was calculated using the data within the first hour.

  3 months

• morbidity indicators

  Morbidity indicators were determined as the length of ICU stay, total hospital stay, re-intubation, surgical revision, complications and re-admission to the ICU.

  3 months

• clinical outcomes

  Clinical outcomes were determined as 7-day mortality and 30-day mortality.

  3 months

Secondary Outcomes (1)

• to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

  3 months

Eligibility Criteria

• Age: 1 Day - 18 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Patients younger than 18 years of age who had undergone congenital heart surgery

You may qualify if:

• Patients younger than 18 years of age who had undergone congenital heart surgery

You may not qualify if:

• emergency operations Patients staying in intensive care unit for less than 24 hours

Sponsors & Collaborators

• Antalya Training and Research Hospital: lead
• Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital: collaborator
• Haydarpasa Numune Training and Research Hospital: collaborator

Study Sites (1)

siyami ersek TRH

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular Abnormalities; Cardiovascular Diseases; Heart Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Months
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: April 9, 2021
• First Posted: April 19, 2021
• Study Start: February 1, 2019
• Primary Completion: May 1, 2019
• Study Completion: May 1, 2019
• Last Updated: September 7, 2022

Record last verified: 2022-09

Locations

TU (1)